41-1
41st Parliament,
1st Session
(June 2, 2011 - September 13, 2013)
Select a different session
Meeting Detail
Study on prescription pharmaceuticals in Canada
Topic:
Witnesses
- Nita Arora, Regional Head Affiliate Management, North America(Hoffmann-La Roche Ltd.)
- Peter Brenders, President and Chief Executive Officer(BIOTECanada)
- Ken Hughes, Vice-President, Scientific and Regulatory Affairs(Rx&D)
- Dr Clive Ward-Able, Executive Director, Research and Development(Amgen Canada Inc.)
- Russell Williams, President(Rx&D)
Meeting with interpretation and transcription